-
1
-
-
1942453711
-
Urotensin II: The old kid in town
-
For reviews, see: (a)
-
For reviews, see: (a) Onan, D.; Hannan, R. D.; Thomas, W. G. Urotensin II: the old kid in town.TrendsEndocrinol.Metab. 2004, 15, 175-182.
-
(2004)
TrendsEndocrinol.Metab.
, vol.15
, pp. 175-182
-
-
Onan, D.1
Hannan, R.D.2
Thomas, W.G.3
-
2
-
-
85047692552
-
Urotensin-II and the cardiovascular system - The importance of developing modulators
-
(b) Doggrell, S. A. Urotensin-II and the cardiovascular system - the importance of developing modulators. Expert Opin. Investig. Drugs 2004, 13, 479-487.
-
(2004)
Expert Opin. Investig. Drugs
, vol.13
, pp. 479-487
-
-
Doggrell, S.A.1
-
3
-
-
0842266248
-
From "gills to pills": Urotensin-II as a regulator of mammalian cardiorenal function
-
(c) Douglas, S. A.; Dhanak, D.; Johns, D. G. From "gills to pills": urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol. Sci. 2004, 25, 76-85.
-
(2004)
Trends Pharmacol. Sci.
, vol.25
, pp. 76-85
-
-
Douglas, S.A.1
Dhanak, D.2
Johns, D.G.3
-
4
-
-
20044372934
-
Urotensin II: Its function in health and its role in disease
-
(d) Ong, K. L.; Lam, K. S. L.; Cheung, B. M. Y. Urotensin II: its function in health and its role in disease. Cardiovasc. Drugs Ther. 2005, 19, 65-75.
-
(2005)
Cardiovasc. Drugs Ther.
, vol.19
, pp. 65-75
-
-
Ong, K.L.1
Lam, K.S.L.2
Cheung, B.M.Y.3
-
6
-
-
42049109932
-
Biological properties and functional determinants of the urotensin II receptor
-
(f) Proulx, C. D.; Holleran, B. J.; Lavigne, P.; Escher, E.; Guillemette, G.; Leduc, R. Biological properties and functional determinants of the urotensin II receptor. Peptides 2008, 29, 691-699.
-
(2008)
Peptides
, vol.29
, pp. 691-699
-
-
Proulx, C.D.1
Holleran, B.J.2
Lavigne, P.3
Escher, E.4
Guillemette, G.5
Leduc, R.6
-
7
-
-
77950552273
-
Urotensin-II receptor modulators as potential drugs
-
in press
-
(g) Maryanoff, B. E.; Kinney, W. A. Urotensin-II receptor modulators as potential drugs. J. Med. Chem., in press.
-
J. Med. Chem.
-
-
Maryanoff, B.E.1
Kinney, W.A.2
-
8
-
-
0012963711
-
Urotensin II: A somatostatin-like peptide in the caudal neurosecretory system of fishes
-
(a) Pearson,D.; Shively, J. E.; Clark, B.R.;Geschwind, I. I; Barkley, M.; Nishioka, R. S.; Bern, H. A. Urotensin II: A somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5021-5024.
-
(1980)
Proc. Natl. Acad. Sci. U.S.A.
, vol.77
, pp. 5021-5024
-
-
Pearson, D.1
Shively, J.E.2
Clark, B.R.3
Geschwind, I.I.4
Barkley, M.5
Nishioka, R.S.6
Bern, H.A.7
-
9
-
-
0032428160
-
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene inmotoneurons of the spinal cord
-
(b) Coulouarn, Y.; Lihrmann, I.; Jegou, S.; Anouar, Y.; Tostivint, H.; Beauvillain, J. C.; Conlon, J. M.; Bern, H. A.; Vaudry, H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene inmotoneurons of the spinal cord. Proc.Natl. Acad. Sci. U.S.A. 1998, 95, 15803-15808.
-
(1998)
Proc.Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 15803-15808
-
-
Coulouarn, Y.1
Lihrmann, I.2
Jegou, S.3
Anouar, Y.4
Tostivint, H.5
Beauvillain, J.C.6
Conlon, J.M.7
Bern, H.A.8
Vaudry, H.9
-
10
-
-
0033575930
-
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
-
(c) Ames, R. S.; Sarau, H. M.; Chambers, J. K.; Willette, R. N.; Aiyar, N. V.; Romanic, A. M.; Louden, C. S.; Foley, J. J.; Sauermelch, C. F.; Coatney, R. W.; Ao, Z.; Disa, J.; Holmes, S. D.; Stadel, J. M.; Martin, J. D.; Liu, W.-S.; Glover, G. I.; Wilson, S.; McNulty, D. E.; Ellis, C. E.; Elshourbagy, N. A.; Shabon, U.; Trill, J. J.; Hay, D. W. P.; Ohlstein, E. H.; Bergsma, D. J.; Douglas, S. A. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999, 401, 282-286. (Pubitemid 129515542)
-
(1999)
Nature
, vol.401
, Issue.6750
, pp. 282-286
-
-
Ames, R.S.1
Sarau, H.M.2
Chambers, J.K.3
Willette, R.N.4
Aiyar, N.V.5
Romanic, A.M.6
Louden, C.S.7
Foley, J.J.8
Sauermelch, C.F.9
Coatney, R.W.10
Ao, Z.11
Disa, J.12
Holmes, S.D.13
Stadel, J.M.14
Martin, J.D.15
Liu, W.-S.16
Glover, G.I.17
Wilson, S.18
McNulty, D.E.19
Ellis, C.E.20
Elshourbagy, N.A.21
Shabon, U.22
Trill, J.J.23
Hay, D.W.P.24
Ohlstein, E.H.25
Bergsma, D.J.26
Douglas, S.A.27
more..
-
11
-
-
0036261206
-
Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey
-
(d) Elshourbagy, N. A.; Douglas, S. A.; Shabon, U.; Harrison, S.; Duddy, G.; Sechler, J. L.; Ao, Z.; Maleeff, B. E.; Naselsky, D.; Disa, J.; Aiyar, N. V. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br. J. Pharmacol. 2002, 136, 9-22.
-
(2002)
Br. J. Pharmacol.
, vol.136
, pp. 9-22
-
-
Elshourbagy, N.A.1
Douglas, S.A.2
Shabon, U.3
Harrison, S.4
Duddy, G.5
Sechler, J.L.6
Ao, Z.7
Maleeff, B.E.8
Naselsky, D.9
Disa, J.10
Aiyar, N.V.11
-
12
-
-
42049091846
-
Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function
-
(e) Maguire, J. J.; Kuc, R. E.; Kleinz, M. J.; Davenport, A. P. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Peptides 2008, 29, 735-742.
-
(2008)
Peptides
, vol.29
, pp. 735-742
-
-
Maguire, J.J.1
Kuc, R.E.2
Kleinz, M.J.3
Davenport, A.P.4
-
13
-
-
0037171726
-
Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II
-
(a) Flohr, S.; Kurz, M.; Kostenis, E.; Brkovich, A.; Fournier, A.; Klabunde, T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 2002, 45, 1799-1805.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 1799-1805
-
-
Flohr, S.1
Kurz, M.2
Kostenis, E.3
Brkovich, A.4
Fournier, A.5
Klabunde, T.6
-
14
-
-
0037118881
-
Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model
-
(b) Kinney, W. A.; Almond, H. R., Jr.; Qi, J.; Smith, C. E.; Santulli, R. J.; de Garavilla, L.; Andrade-Gordon, P.; Cho, D. S.; Everson, A. M.; Feinstein, M. A.; Leung, P. A.; Maryanoff, B. E. Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model. Angew. Chem., Int. Ed. 2002, 41, 2940-2944.
-
(2002)
Angew. Chem., Int. Ed.
, vol.41
, pp. 2940-2944
-
-
Kinney, W.A.1
Almond Jr., H.R.2
Qi, J.3
Smith, C.E.4
Santulli, R.J.5
De Garavilla, L.6
Andrade-Gordon, P.7
Cho, D.S.8
Everson, A.M.9
Feinstein, M.A.10
Leung, P.A.11
Maryanoff, B.E.12
-
15
-
-
0041430625
-
Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay
-
(c) Brkovic, A.; Hattenberger, A.; Kostenis, E.; Klabunde, T.; Flohr, S.; Kurz, M.; Bourgault, S.; Fournier, A. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. J. Pharmacol. Exp. Ther. 2003, 306, 1200-1209.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.306
, pp. 1200-1209
-
-
Brkovic, A.1
Hattenberger, A.2
Kostenis, E.3
Klabunde, T.4
Flohr, S.5
Kurz, M.6
Bourgault, S.7
Fournier, A.8
-
16
-
-
0030174350
-
Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates
-
Conlon, J. M.; Yano, K.; Waugh, D.; Hazon, N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J. Exp. Zool. 1996, 275, 226-238.
-
(1996)
J. Exp. Zool.
, vol.275
, pp. 226-238
-
-
Conlon, J.M.1
Yano, K.2
Waugh, D.3
Hazon, N.4
-
17
-
-
0036157935
-
Urotensin II evokes potent vasoconstriction in humans in vivo
-
Bohm, F.; Pernow, J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br. J. Pharmacol. 2002, 135, 25-27.
-
(2002)
Br. J. Pharmacol.
, vol.135
, pp. 25-27
-
-
Bohm, F.1
Pernow, J.2
-
18
-
-
0034466374
-
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease
-
Douglas, S. A.; Ohlstein, E. H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc. Med. 2000, 10, 229-237.
-
(2000)
Trends Cardiovasc. Med.
, vol.10
, pp. 229-237
-
-
Douglas, S.A.1
Ohlstein, E.H.2
-
19
-
-
0035030726
-
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats
-
Gardiner, S. M.; March, J. E.; Kemp, P. A.; Davenport, A. P.; Bennett, T. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br. J. Pharmacol. 2001, 132, 1625-1629.
-
(2001)
Br. J. Pharmacol.
, vol.132
, pp. 1625-1629
-
-
Gardiner, S.M.1
March, J.E.2
Kemp, P.A.3
Davenport, A.P.4
Bennett, T.5
-
20
-
-
0035834370
-
Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats
-
DOI 10.1016/S0014-5793(01)03015-0, PII S0014579301030150
-
Zou, Y.; Nagai, R.; Yamazaki, T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 2001, 508, 57-60. (Pubitemid 33055667)
-
(2001)
FEBS Letters
, vol.508
, Issue.1
, pp. 57-60
-
-
Zou, Y.1
Nagai, R.2
Yamazaki, T.3
-
21
-
-
0035800017
-
Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells
-
Watanabe, T.; Pakala, R.; Katagiri, T.; Benedict, C. R. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 2001, 104, 16-18.
-
(2001)
Circulation
, vol.104
, pp. 16-18
-
-
Watanabe, T.1
Pakala, R.2
Katagiri, T.3
Benedict, C.R.4
-
22
-
-
0035208378
-
Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues
-
DOI 10.1097/00004872-200112000-00011
-
(a) Matsushita, M.; Shichiri, M.; Imai, T.; Iwashina, M.; Tanaka, H.; Takasu, N.; Hirata, Y. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J. Hypertens. 2001, 19, 2185-2190. (Pubitemid 33135240)
-
(2001)
Journal of Hypertension
, vol.19
, Issue.12
, pp. 2185-2190
-
-
Matsushita, M.1
Shichiri, M.2
Imai, T.3
Iwashina, M.4
Tanaka, H.5
Takasu, N.6
Hirata, Y.7
-
23
-
-
34047250447
-
Therapeutic potential of blockade of the urotensin II system in systemic hypertension
-
(b) Krum, H.; Kemp,W. Therapeutic potential of blockade of the urotensin II system in systemic hypertension. Curr. Hypertens. Rep. 2007, 9, 53-58.
-
(2007)
Curr. Hypertens. Rep.
, vol.9
, pp. 53-58
-
-
Krum, H.1
Kemp, W.2
-
24
-
-
0037042532
-
Congestive heart failure and expression of myocardial urotensin II
-
(a) Douglas, S. A.; Tayara, L.; Ohlstein, E. H.; Halawa, N.; Giaid, A. Congestive heart failure and expression of myocardial urotensin II. Lancet 2002, 359, 1990-1997.
-
(2002)
Lancet
, vol.359
, pp. 1990-1997
-
-
Douglas, S.A.1
Tayara, L.2
Ohlstein, E.H.3
Halawa, N.4
Giaid, A.5
-
25
-
-
0042525995
-
Direct actions of urotensin II on the heart. Implications for cardiac fibrosis and hypertrophy
-
(b) Tzanidis, A.; Hannan, R. D.; Thomas,W. G.; Onan, D.; Autelitano,D. J.; See, F.; Kelly, D. J.; Gilbert, R. E.; Krum, H. Direct actions of urotensin II on the heart. Implications for cardiac fibrosis and hypertrophy. Circ. Res. 2003, 93, 246-253.
-
(2003)
Circ. Res.
, vol.93
, pp. 246-253
-
-
Tzanidis, A.1
Hannan, R.D.2
Thomas, W.G.3
Onan, D.4
Autelitano, D.J.5
See, F.6
Kelly, D.J.7
Gilbert, R.E.8
Krum, H.9
-
26
-
-
42049105098
-
Cardiorenovascular effects of urotensin II and the relevance of the UT receptor
-
(c) Tolle, M.; van der Giet, M. Cardiorenovascular effects of urotensin II and the relevance of the UT receptor. Peptides 2008, 29, 743-763.
-
(2008)
Peptides
, vol.29
, pp. 743-763
-
-
Tolle, M.1
Van Der Giet, M.2
-
27
-
-
0035828410
-
Role of urotensin II in patients on dialysis
-
(a) Totsune, K.; Takahashi, K.; Arihara, Z.; Sone, M.; Satoh, F.; Ito, S.; Kimura, Y.; Sasano, H.; Murakami, O. Role of urotensin II in patients on dialysis. Lancet 2001, 358, 810-811.
-
(2001)
Lancet
, vol.358
, pp. 810-811
-
-
Totsune, K.1
Takahashi, K.2
Arihara, Z.3
Sone, M.4
Satoh, F.5
Ito, S.6
Kimura, Y.7
Sasano, H.8
Murakami, O.9
-
28
-
-
7444244979
-
Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy
-
(b) Langham, R. G.; Kelly, D. J.; Gow, R. M.; Zhang, Y.; Dowling, J. K.; Thomson, N. M.; Gilbert, R. E. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Am. J. Kidney Dis. 2004, 44, 826-831.
-
(2004)
Am. J. Kidney Dis.
, vol.44
, pp. 826-831
-
-
Langham, R.G.1
Kelly, D.J.2
Gow, R.M.3
Zhang, Y.4
Dowling, J.K.5
Thomson, N.M.6
Gilbert, R.E.7
-
29
-
-
0037287386
-
Increased plasma urotensin II levels in patients with diabetes mellitus
-
(a) Totsune, K.; Takahashi, K.; Arihara, Z.; Sone, M.; Ito, S.; Murakami, O. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin. Sci. 2003, 104, 1-5.
-
(2003)
Clin. Sci.
, vol.104
, pp. 1-5
-
-
Totsune, K.1
Takahashi, K.2
Arihara, Z.3
Sone, M.4
Ito, S.5
Murakami, O.6
-
30
-
-
0042071570
-
Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects
-
DOI 10.1007/s00125-003-1145-1
-
(b) Wenyi, Z.; Suzuki, S.; Hirai, M.; Hinokio, Y.; Tanizawa, Y.; Matsutani, A.; Satoh, J.; Oka, Y. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003, 46, 972-976. (Pubitemid 36961321)
-
(2003)
Diabetologia
, vol.46
, Issue.7
, pp. 972-976
-
-
Wenyi, Z.1
Suzuki, S.2
Hirai, M.3
Hinokio, Y.4
Tanizawa, Y.5
Matsutani, A.6
Satoh, J.7
Oka, Y.8
-
31
-
-
42149115655
-
The role of urotensin II in the metabolic syndrome
-
(c) Ong, K. L.;Wong, L. Y. F.; Cheung, B. M. Y. The role of urotensin II in the metabolic syndrome. Peptides 2008, 29, 859-867.
-
(2008)
Peptides
, vol.29
, pp. 859-867
-
-
Ong, K.L.1
Wong, L.Y.F.2
Cheung, B.M.Y.3
-
32
-
-
33646573374
-
Human urotensin II and metabolic syndrome
-
(a) Watanabe, T.; Kanome, T.; Suguro, T.; Miyazaki, A. Human urotensin II and metabolic syndrome. Vasc. Dis. Prev. 2006, 3, 91-98.
-
(2006)
Vasc. Dis. Prev.
, vol.3
, pp. 91-98
-
-
Watanabe, T.1
Kanome, T.2
Suguro, T.3
Miyazaki, A.4
-
33
-
-
4043172801
-
Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta
-
DOI 10.1016/j.atherosclerosis.2004.03.023, PII S0021915004002308
-
(b) Bousette, N.; Patel, L.; Douglas, S. A.; Ohlstein, E. H.; Giaid, A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 2004, 176, 117-123. (Pubitemid 39078653)
-
(2004)
Atherosclerosis
, vol.176
, Issue.1
, pp. 117-123
-
-
Bousette, N.1
Patel, L.2
Douglas, S.A.3
Ohlstein, E.H.4
Giaid, A.5
-
34
-
-
42149166623
-
Urotensin II and atherosclerosis
-
(c) Loirand, G.; Rolli-Derkinderen, M.; Pacaud, P. Urotensin II and atherosclerosis. Peptides 2008, 29, 778-782.
-
(2008)
Peptides
, vol.29
, pp. 778-782
-
-
Loirand, G.1
Rolli-Derkinderen, M.2
Pacaud, P.3
-
35
-
-
35648974717
-
Phenylpiperidinebenzoxazinones as urotensin-II receptor antagonists: Synthesis, SAR, and in vivo assessment
-
Luci, D. K.; Ghosh, S.; Smith, C. E.; Qi, J.; Wang, Y.; Haertlein, B.; Parry, T. J.; Li, J.; Almond, H. R.; Minor, L. K.; Damiano, B. P.; Kinney, W. A.; Maryanoff, B. E.; Lawson, E. C. Phenylpiperidinebenzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment. Bioorg. Med. Chem. Lett. 2007, 17, 6489-6492.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 6489-6492
-
-
Luci, D.K.1
Ghosh, S.2
Smith, C.E.3
Qi, J.4
Wang, Y.5
Haertlein, B.6
Parry, T.J.7
Li, J.8
Almond, H.R.9
Minor, L.K.10
Damiano, B.P.11
Kinney, W.A.12
Maryanoff, B.E.13
Lawson, E.C.14
-
36
-
-
33645753473
-
Non-peptidic urotensin- II receptor modulators
-
For reviews, see: (a)
-
For reviews, see: (a) Jin, J.; Douglas, S. A. Non-peptidic urotensin- II receptor modulators. Expert Opin. Ther. Pat. 2006, 16, 467-479.
-
(2006)
Expert Opin. Ther. Pat.
, vol.16
, pp. 467-479
-
-
Jin, J.1
Douglas, S.A.2
-
37
-
-
33645886956
-
Urotensin-II receptor antagonists
-
(b) Carotenuto, A.; Grieco, P.; Rovero, P.; Novellino, E. Urotensin-II receptor antagonists. Curr. Med. Chem. 2006, 13, 267-275.
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 267-275
-
-
Carotenuto, A.1
Grieco, P.2
Rovero, P.3
Novellino, E.4
-
38
-
-
42049110102
-
Nonpeptide urotensin-II receptor agonists and antagonists: Review and structure-activity relationships
-
(c) Lescot, E.; Bureau, R.; Rault, S. Nonpeptide urotensin-II receptor agonists and antagonists: review and structure-activity relationships. Peptides 2008, 29, 680-690.
-
(2008)
Peptides
, vol.29
, pp. 680-690
-
-
Lescot, E.1
Bureau, R.2
Rault, S.3
-
39
-
-
42949164575
-
2-Aminomethyl piperidines as novel urotensin-II receptor antagonists
-
(a) Jin, J.; Wang, Y.; Wang, F.; Shi, D.; Erhard, K. F.; Wu, Z.; Guida, B. F.; Lawrence, S. K.; Behm, D. J.; Disa, J.; Vaidya, K. S.; Evans,C.; McMillan, L. J.; Rivero,R.A.; Neeb,M. J.; Douglas, S. A. 2-Aminomethyl piperidines as novel urotensin-II receptor antagonists. Bioorg.Med. Chem. Lett. 2008, 18, 2860-2864.
-
(2008)
Bioorg.Med. Chem. Lett.
, vol.18
, pp. 2860-2864
-
-
Jin, J.1
Wang, Y.2
Wang, F.3
Shi, D.4
Erhard, K.F.5
Wu, Z.6
Guida, B.F.7
Lawrence, S.K.8
Behm, D.J.9
Disa, J.10
Vaidya, K.S.11
Evans, C.12
McMillan, L.J.13
Rivero, R.A.14
Neeb, M.J.15
Douglas, S.A.16
-
40
-
-
20444369889
-
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists
-
(b) Jin, J.; Dhanak, D.; Knight, S. D.; Widdowson, K.; Aiyar, N.; Naselsky, D.; Sarau, H. M.; Foley, J. J.; Schmidt, D. B.; Bennett, C. D.; Wang, B.; Warren, G. L.; Moore, M. L.; Keenan, R. M.; Rivero, R. A.; Douglas, S. A. Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists. Bioorg.Med. Chem. Lett. 2005, 15, 3229-3232.
-
(2005)
Bioorg.Med. Chem. Lett.
, vol.15
, pp. 3229-3232
-
-
Jin, J.1
Dhanak, D.2
Knight, S.D.3
Widdowson, K.4
Aiyar, N.5
Naselsky, D.6
Sarau, H.M.7
Foley, J.J.8
Schmidt, D.B.9
Bennett, C.D.10
Wang, B.11
Warren, G.L.12
Moore, M.L.13
Keenan, R.M.14
Rivero, R.A.15
Douglas, S.A.16
-
41
-
-
33644754588
-
The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats
-
(c) Clozel, M.; Hess, P.; Qiu, C.; Ding, S. S.; Rey, M. The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. J. Pharmacol. Exp. Ther. 2006, 316, 1115-1121.
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.316
, pp. 1115-1121
-
-
Clozel, M.1
Hess, P.2
Qiu, C.3
Ding, S.S.4
Rey, M.5
-
42
-
-
44649143790
-
Development of potent and selective small-molecule human urotensin-II antagonists
-
(d) McAtee, J. J.; Dodson, J. W.; Dowdell, S. E.; Girard, G. R.; Goodman, K. B.; Hilfiker, M. A.; Sehon, C. A.; Sha, D.; Wang, G. Z.; Wang, N.; Viet, A. Q.; Zhang, D.; Aiyar, N. V.; Behm, D. J.; Carballo, L.H.; Evans, C. A.; Fries, H. E.; Nagilla, R.; Roethke, T. J.; Xu, X.; Yuan, C. C. K.; Douglas, S. A.; Neeb, M. J. Development of potent and selective small-molecule human urotensin-II antagonists. Bioorg. Med. Chem. Lett. 2008, 18, 3500-3503.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 3500-3503
-
-
McAtee, J.J.1
Dodson, J.W.2
Dowdell, S.E.3
Girard, G.R.4
Goodman, K.B.5
Hilfiker, M.A.6
Sehon, C.A.7
Sha, D.8
Wang, G.Z.9
Wang, N.10
Viet, A.Q.11
Zhang, D.12
Aiyar, N.V.13
Behm, D.J.14
Carballo, L.H.15
Evans, C.A.16
Fries, H.E.17
Nagilla, R.18
Roethke, T.J.19
Xu, X.20
Yuan, C.C.K.21
Douglas, S.A.22
Neeb, M.J.23
more..
-
43
-
-
44849120712
-
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles
-
(e) McAtee, J. J.; Dodson, J. W.; Dowdell, S. E.; Erhard, K.; Girard, G. R.; Goodman, K. B.; Hilfiker, M. A.; Jin, J.; Sehon, C. A.; Sha, D.; Shi, D.; Wang, F.; Wang, G. Z.; Wang, N.; Wang, Y.; Viet, A. Q.; Yuan, C. C. K.; Zhang, D.; Aiyar, N. V.; Behm, D. J.; Carballo, L. H.; Evans, C. A.; Fries, H. E.; Nagilla, R.; Roethke, T. J.; Xu, X.; Douglas, S. A.; Neeb, M. J. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles. Bioorg. Med. Chem. Lett. 2008, 18, 3716-3719.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 3716-3719
-
-
McAtee, J.J.1
Dodson, J.W.2
Dowdell, S.E.3
Erhard, K.4
Girard, G.R.5
Goodman, K.B.6
Hilfiker, M.A.7
Jin, J.8
Sehon, C.A.9
Sha, D.10
Shi, D.11
Wang, F.12
Wang, G.Z.13
Wang, N.14
Wang, Y.15
Viet, A.Q.16
Yuan, C.C.K.17
Zhang, D.18
Aiyar, N.V.19
Behm, D.J.20
Carballo, L.H.21
Evans, C.A.22
Fries, H.E.23
Nagilla, R.24
Roethke, T.J.25
Xu, X.26
Douglas, S.A.27
Neeb, M.J.28
more..
-
44
-
-
47149105824
-
Urotensin-II receptor antagonists: Synthesis and SAR of N-cyclic azaalkyl benzamides
-
(f) Jin, J.; An, M.; Sapienza, A.; Aiyar, N.; Naselsky, D.; Sarau, H. M.; Foley, J. J.; Salyers, K. L.; Knight, S. D.; Keenan, R. M.; Rivero, R. A.; Dhanak, D.; Douglas, S. A. Urotensin-II receptor antagonists: Synthesis and SAR of N-cyclic azaalkyl benzamides. Bioorg. Med. Chem. Lett. 2008, 18, 3950-3954.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 3950-3954
-
-
Jin, J.1
An, M.2
Sapienza, A.3
Aiyar, N.4
Naselsky, D.5
Sarau, H.M.6
Foley, J.J.7
Salyers, K.L.8
Knight, S.D.9
Keenan, R.M.10
Rivero, R.A.11
Dhanak, D.12
Douglas, S.A.13
-
45
-
-
48649096711
-
Aminomethylpiperazines as selective urotensin antagonists
-
(g) Hilfiker, M. A.; Zhang, D.; Dowdell, S. E.; Goodman, K. B.; McAtee, J. J.; Dodson, J. W.; Viet, A. Q.; Wang, G. Z.; Sehon, C. A.; Behm, D. J.; Wu, Z.; Carballo, L. H.; Douglas, S. A.; Neeb, M. J. Aminomethylpiperazines as selective urotensin antagonists. Bioorg. Med. Chem. Lett. 2008, 18, 4470-4473.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4470-4473
-
-
Hilfiker, M.A.1
Zhang, D.2
Dowdell, S.E.3
Goodman, K.B.4
McAtee, J.J.5
Dodson, J.W.6
Viet, A.Q.7
Wang, G.Z.8
Sehon, C.A.9
Behm, D.J.10
Wu, Z.11
Carballo, L.H.12
Douglas, S.A.13
Neeb, M.J.14
-
46
-
-
51349098135
-
N-Alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists
-
(h) Wang, Y.; Wu, Z.; Guida, B. F.; Lawrence, S. K.; Neeb, M. J.; Rivero, R. A.; Douglas, S. A.; Jin, J. N-Alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists. Bioorg. Med. Chem. Lett. 2008, 18, 4936-4939.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4936-4939
-
-
Wang, Y.1
Wu, Z.2
Guida, B.F.3
Lawrence, S.K.4
Neeb, M.J.5
Rivero, R.A.6
Douglas, S.A.7
Jin, J.8
-
47
-
-
4644332005
-
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)-ethyl]-3-(2-methylquinolin- 4-yl)urea sulfate salt): First demonstration of a pathophysiological role of the urotensin system
-
(i) Clozel, M.; Binkert, C.; Birker-Robaczewska, M.; Boukhadra, C.; Ding, S.-S.; Fischli, W.; Hess, P.; Mathys, B.; Morrison, K.; Mueller, C.; Mueller, C.; Nayler, O.; Qiu, C.; Rey, M.; Scherz, M. W.; Velker, J.; Weller, T.; Xi, J.-F.; Ziltener, P. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)-ethyl]-3-(2- methylquinolin-4-yl)urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J. Pharmacol. Exp. Ther. 2004, 311, 204-212.
-
(2004)
J. Pharmacol. Exp. Ther.
, vol.311
, pp. 204-212
-
-
Clozel, M.1
Binkert, C.2
Birker-Robaczewska, M.3
Boukhadra, C.4
Ding, S.-S.5
Fischli, W.6
Hess, P.7
Mathys, B.8
Morrison, K.9
Mueller, C.10
Mueller, C.11
Nayler, O.12
Qiu, C.13
Rey, M.14
Scherz, M.W.15
Velker, J.16
Weller, T.17
Xi, J.-F.18
Ziltener, P.19
-
48
-
-
27844466269
-
N-Methoxy-N-methylamides as effective acylating agents
-
Nahm, S.; Weinreb, S. M. N-Methoxy-N-methylamides as effective acylating agents. Tetrahedron Lett. 1981, 22, 3815-3818.
-
(1981)
Tetrahedron Lett.
, vol.22
, pp. 3815-3818
-
-
Nahm, S.1
Weinreb, S.M.2
-
49
-
-
0036065054
-
A simple protocol for the one pot synthesis of chiral secondary benzylic alcohols by catalytic enantioselective reduction of aromatic ketones
-
Ponzo, V. L.; Kaufman, T. S. A simple protocol for the one pot synthesis of chiral secondary benzylic alcohols by catalytic enantioselective reduction of aromatic ketones. Synlett 2002, 7, 1128-1130.
-
(2002)
Synlett
, vol.7
, pp. 1128-1130
-
-
Ponzo, V.L.1
Kaufman, T.S.2
-
50
-
-
33751183730
-
Mild and selective palladium(0)-catalyzed deallylation of allylic amines. Allylamine and diallylamine as very convenient ammonia equivalents for the synthesis of primary amines
-
Garro-Helion, F.; Merzouk, A.; Guibe, F. Mild and selective palladium(0)-catalyzed deallylation of allylic amines. Allylamine and diallylamine as very convenient ammonia equivalents for the synthesis of primary amines. J. Org. Chem. 1993, 58, 6109-6113.
-
(1993)
J. Org. Chem.
, vol.58
, pp. 6109-6113
-
-
Garro-Helion, F.1
Merzouk, A.2
Guibe, F.3
-
51
-
-
0345276532
-
Highly enantioselective hydrogen- Transfer reductive amination: Catalytic asymmetric synthesis of primary amines
-
(a) Kadyrov, R; Riermeier, T. H. Highly enantioselective hydrogen- transfer reductive amination: catalytic asymmetric synthesis of primary amines. Angew. Chem., Int. Ed. 2003, 42, 5472-5474.
-
(2003)
Angew. Chem., Int. Ed.
, vol.42
, pp. 5472-5474
-
-
Kadyrov, R.1
Riermeier, T.H.2
-
52
-
-
72249118825
-
-
Each enantiomer of intermediate XV was analyzed by chiral HPLC (seeExperimental Section)
-
(b) Each enantiomer of intermediate XV was analyzed by chiral HPLC (seeExperimental Section).
-
-
-
-
53
-
-
0037031625
-
Aqueous hydroxide as a base for palladium-catalyzed amination of aryl chlorides and bromides
-
Kuwano, R.; Utsunomiya, M.; Hartwig, J. F. Aqueous hydroxide as a base for palladium-catalyzed amination of aryl chlorides and bromides. J. Org. Chem. 2002, 67, 6479-6486.
-
(2002)
J. Org. Chem.
, vol.67
, pp. 6479-6486
-
-
Kuwano, R.1
Utsunomiya, M.2
Hartwig, J.F.3
-
54
-
-
72249098091
-
-
50 value of 460 nM
-
50 value of 460 nM.
-
-
-
-
55
-
-
14744274245
-
Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: Comparison with angiotensin II receptors
-
DOI 10.1016/j.peptides.2004.11.018
-
Qi, J.-S.; Minor, L. K.; Smith, C.; Hu, B.; Yang, J.; Andrade- Gordon, P.; Damiano, B. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 2005, 26, 683-690. (Pubitemid 40326887)
-
(2005)
Peptides
, vol.26
, Issue.4
, pp. 683-690
-
-
Qi, J.-S.1
Minor, L.K.2
Smith, C.3
Hu, B.4
Yang, J.5
Andrade-Gordon, P.6
Damiano, B.7
-
56
-
-
72249085771
-
-
50=150 nM)
-
50=150 nM).
-
-
-
-
57
-
-
22744447609
-
Nonpeptidic urotensin- II receptor antagonists I: In vitro pharmacological characterization of SB-706375
-
Douglas, S. A.; Behm, D. J.; Aiyar, N. V.; Naselsky, D.; Disa, J.; Brooks, D. P.; Ohlstein, E. H.; Gleason, J. G.; Sarau, H. M.; Foley, J. J.; Buckley, P. T.; Schmidt, D. B.; Wixted,W. E.; Widdowson, K.; Riley, G.; Jin, J.; Gallagher, T. F.; Schmidt, S. J.; Ridgers, L.; Christmann, L. T.; Keenan, R. M.; Knight, S. D.; Dhanak, D. Nonpeptidic urotensin- II receptor antagonists I: in vitro pharmacological characterization of SB-706375. Br. J. Pharmacol. 2005, 145, 620-635.
-
(2005)
Br. J. Pharmacol.
, vol.145
, pp. 620-635
-
-
Douglas, S.A.1
Behm, D.J.2
Aiyar, N.V.3
Naselsky, D.4
Disa, J.5
Brooks, D.P.6
Ohlstein, E.H.7
Gleason, J.G.8
Sarau, H.M.9
Foley, J.J.10
Buckley, P.T.11
Schmidt, D.B.12
Wixted, W.E.13
Widdowson, K.14
Riley, G.15
Jin, J.16
Gallagher, T.F.17
Schmidt, S.J.18
Ridgers, L.19
Christmann, L.T.20
Keenan, R.M.21
Knight, S.D.22
Dhanak, D.23
more..
-
58
-
-
0038606902
-
The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors
-
Herold, C. L.; Behm, D. J.; Buckley, P. T.; Foley, J. J.; Wixted, W. E.; Sarau, H. M.; Douglas, S. A. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors. Br. J. Pharmacol. 2003, 139, 203-207.
-
(2003)
Br. J. Pharmacol.
, vol.139
, pp. 203-207
-
-
Herold, C.L.1
Behm, D.J.2
Buckley, P.T.3
Foley, J.J.4
Wixted, W.E.5
Sarau, H.M.6
Douglas, S.A.7
-
59
-
-
33847109791
-
Urotensin-II induces ear flushing in rats
-
Qi, J.; Schulingkamp, R.; Parry, T. J.; Colburn, R.; Stone, D.; Haertlein, B.; Minor, L. K.; Andrade-Gordon, P.; Damiano, B. P. Urotensin-II induces ear flushing in rats. Br. J. Pharmacol. 2007, 150, 415-423.
-
(2007)
Br. J. Pharmacol.
, vol.150
, pp. 415-423
-
-
Qi, J.1
Schulingkamp, R.2
Parry, T.J.3
Colburn, R.4
Stone, D.5
Haertlein, B.6
Minor, L.K.7
Andrade-Gordon, P.8
Damiano, B.P.9
-
60
-
-
72249106860
-
-
Cerep Seattle, WA; an independent contract laboratory, performed standardized binding assays on receptors and ion channels. Each results was expressed as percent inhibition of a control specific binding (mean values, n=2; h, human)
-
Cerep (Seattle, WA; www.cerep.com), an independent contract laboratory, performed standardized binding assays on receptors and ion channels. Each results was expressed as percent inhibition of a control specific binding (mean values, n=2; h, human).
-
-
-
-
61
-
-
72249120159
-
-
note
-
+ channel; Cl- channel; norepinephrine transporter; dopamine transporter.
-
-
-
-
62
-
-
72249110867
-
-
Schrodinger, Inc.: 1500 SW First Avenue, Suite 1180, Portland, OR
-
Maestro 8.5.207; Schrodinger, Inc.: 1500 SW First Avenue, Suite 1180, Portland, OR.
-
Maestro 8.5.207
-
-
-
63
-
-
33645941402
-
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin
-
Jorgensen,W. L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 1988, 110, 1657-1666.
-
(1988)
J. Am. Chem. Soc.
, vol.110
, pp. 1657-1666
-
-
Jorgensen, W.L.1
Tirado-Rives, J.2
-
64
-
-
4043171970
-
The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii
-
Qui, D.; Shenkin, P. S.; Hollinger, F. P.; Still, C. W. The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii. J. Phys. Chem. A 1997, 101, 3005-3014.
-
(1997)
J. Phys. Chem. A
, vol.101
, pp. 3005-3014
-
-
Qui, D.1
Shenkin, P.S.2
Hollinger, F.P.3
Still, C.W.4
-
65
-
-
0142236572
-
Low mode search. An efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides
-
(a) Kolossvary, I.; Guida, W. C. Low mode search. An efficient, automated computational method for conformational analysis: application to cyclic and acyclic alkanes and cyclic peptides. J. Am. Chem. Soc. 1996, 118, 5011-5019.
-
(1996)
J. Am. Chem. Soc.
, vol.118
, pp. 5011-5019
-
-
Kolossvary, I.1
Guida, W.C.2
-
66
-
-
0000147236
-
80 and flexible docking of 9-deazaguanine inhibitors into PNP
-
80 and flexible docking of 9-deazaguanine inhibitors into PNP. J. Comput. Chem. 1999, 20, 1671-1684.
-
(1999)
J. Comput. Chem.
, vol.20
, pp. 1671-1684
-
-
Kolossvary, I.1
Guida, W.C.2
-
67
-
-
72249092059
-
-
Version 3.0; Schrodinger, LLC: New York
-
Phase, Version 3.0; Schrodinger, LLC: New York, 2008.
-
(2008)
Phase
-
-
-
68
-
-
67650245849
-
Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions
-
Luci, D. K.; Lawson, E. C.; Ghosh, S.; Kinney, W. A.; Smith, C. E.; Qi, J.; Wang, Y.; Minor, L. K.; Maryanoff, B. E. Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions. Tetrahedron Lett. 2009, 50, 4958-4961.
-
(2009)
Tetrahedron Lett.
, vol.50
, pp. 4958-4961
-
-
Luci, D.K.1
Lawson, E.C.2
Ghosh, S.3
Kinney, W.A.4
Smith, C.E.5
Qi, J.6
Wang, Y.7
Minor, L.K.8
Maryanoff, B.E.9
-
69
-
-
34247244635
-
Definition of new pharmacophores for nonpeptide antagonists of urotensin-II. Comparison with the 3D-structure of human urotensin- II and URP
-
(a) Lescot, E.; Sopkova-de Oliveira Santos, J.; Dubessy, C.; Oulyadi, H.; Lesnard, A.; Vaudry, H.; Bureau, R.; Rault, S. Definition of new pharmacophores for nonpeptide antagonists of urotensin-II. Comparison with the 3D-structure of human urotensin- II and URP. J. Chem. Inf. Model. 2007, 47, 602-612.
-
(2007)
J. Chem. Inf. Model.
, vol.47
, pp. 602-612
-
-
Lescot, E.1
Sopkova-de Oliveira Santos, J.2
Dubessy, C.3
Oulyadi, H.4
Lesnard, A.5
Vaudry, H.6
Bureau, R.7
Rault, S.8
-
70
-
-
50849111783
-
Three-dimensional model of the human urotensin-II receptor: Docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model
-
(b) Lescot, E.; Sopkova-de Oliveira Santos, J.; Colloc'h, N.; Rodrigo, J.; Milazzo- Segalas, I.; Bureau, R.; Rault, S. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model. Proteins 2008, 73, 173-184.
-
(2008)
Proteins
, vol.73
, pp. 173-184
-
-
Lescot, E.1
Sopkova-de Oliveira Santos, J.2
Colloc'h, N.3
Rodrigo, J.4
Milazzo-Segalas, I.5
Bureau, R.6
Rault, S.7
-
71
-
-
0001797411
-
Asymmetric hydrogenation of 3-oxo carboxylates using BINAP-ruthenium complexes: (R)-(-)-methyl 3-hydroxybutanoate
-
Kitamura, M.; Tokunaga, M.; Ohkuma, T.; Noyori, R. Asymmetric hydrogenation of 3-oxo carboxylates using BINAP-ruthenium complexes: (R)-(-)-methyl 3-hydroxybutanoate. Org. Synth. 1993, 71, 1-13.
-
(1993)
Org. Synth.
, vol.71
, pp. 1-13
-
-
Kitamura, M.1
Tokunaga, M.2
Ohkuma, T.3
Noyori, R.4
-
72
-
-
0028943373
-
A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia
-
(a) Tal, M.; Ammar, D. A.; Karpuj, M.; Krizhanovsky, V.; Naim, M.; Thompson, D. A. A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem. Biophys. Res. Commun. 1995, 209, 752-759.
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.209
, pp. 752-759
-
-
Tal, M.1
Ammar, D.A.2
Karpuj, M.3
Krizhanovsky, V.4
Naim, M.5
Thompson, D.A.6
-
73
-
-
0029102720
-
Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors
-
(b) Marchese, A.; Heiber, M.; Nguyen, T.; Heng, H. H.; Saldivia, V. R.; Cheng, R.; Murphy, P. M.; Tsui, L. C.; Shi, X.; Gregor, P. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 1995, 29, 335-344.
-
(1995)
Genomics
, vol.29
, pp. 335-344
-
-
Marchese, A.1
Heiber, M.2
Nguyen, T.3
Heng, H.H.4
Saldivia, V.R.5
Cheng, R.6
Murphy, P.M.7
Tsui, L.C.8
Shi, X.9
Gregor, P.10
|